ID   A549 HLA-B*08:01
AC   CVCL_C3CL
DR   cancercelllines; CVCL_C3CL
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310524
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*08:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//